Evaluation of a Novel Nicotine Inhaler Device: Part 1-Arterial and Venous Pharmacokinetics

摘要

Introduction: In the United Kingdom, licensed nicotine-containing products can be recommended to reduce the harm associated with smoking. Many smokers find currently available nicotine replacement products unsatisfactory. The arterial and venous pharmacokinetics (PK) of nicotine delivered via a novel inhaler device were determined.